IL22 and influenza: Anti-IL-22BP may have therapeutic value for influenza infection, as a pro-IL-22 environment was shown to alleviate pulmonary inflammation in IL-22BP-knockout mice (IL-22RA2−/−) during H1N1 (PR8/34 H1N1) infection and protected the lung by promoting tight junction formation (112).